¬
¬
J. Perez Sestelo L. A. Sarandeses and R. M. Suarez
FULL PAPER
1212 cmÀ1; 1H NMR (200 MHz, CDCl3, 258C): d 1.05 (s, 9H), 0.83 1.91
(m, 12H), 4.03 (dd, J 10.7, 2.9 Hz, 0.91H), 4.4 (dd, J 7.8, 2.4 Hz, 0.09H),
6.08 (s, 0.91H), 6.20 (s, 0.09H), 7.37 7.61 ppm (m, 5H); 13C NMR
(50 MHz, CDCl3, 258C): d 25.2 (3 Â CH3), 25.8 (CH2), 25.9 (CH2), 26.2
(CH2), 31.4 (CH2), 33.8 (CH2), 34.3 (CH), 36.9 (C), 42.6 (CH2), 55.7 (CH),
95.1 (CH), 126.5 (2 Â CH), 128.8 (2 Â CH), 130.4 (CH), 135.8 (C), 172.4 (C),
23.4 (3 Â CH3), 24.4 (CH2), 28.7 (CH2), 30.2 (CH2), 33.7 (CH2), 51.5 (CH3),
74.8 (CH), 109.3 (CH), 173.4 (C), 173.8 ppm (C); MS (70 eV, EI): m/z (%):
258 (10) [M ], 111 (100); HRMS (FAB): m/z: calcd for C13H23O5: 259.1545
[M H]; found: 259.1545.
(2S,5x)-2-(tert-Butyl)-5-(4-hydroxybutyl)-1,3-dioxolan-4-one (7e:8e): Fol-
lowing the general experimental procedure, a mixture containing dioxo-
lanone 1 (150 mg, 0.96 mmol) and 3-iodo-1-propanol (275 mL, 2.88 mmol)
was treated with CuI (365 mg, 1.92 mmol) and Zn (377 mg, 5.76 mmol) to
give, after column chromatography (20% EtOAc/hexanes), 7e:8e (94 mg,
45%, 92:8, 84% de) as a yellow oil. Rf 0.2 (40% EtOAc/hexanes); IR
173.8 ppm (C); MS (70 eV, EI): m/z (%): 343 (2) [M ], 328 (2) [M À CH3],
286 (78) [M À C4H9], 105 (100); HRMS (EI): m/z: calcd for C21H29NO3:
343.2147 [M ]; found: 343.2147.
Methyl
5-[(2S,4x)-3-benzoyl-2-(tert-butyl)-5-oxo-4-oxazolidinyl]penta-
noate (9d:10d): Following the general experimental procedure, a mixture
containing 2 (80 mg, 0.308 mmol) and methyl 4-iodobutyrate (80 mL,
0.617 mmol) was treated with CuI (117 mg, 0.617 mmol) and Zn (121 mg,
1.848 mmol) to give, after column chromatography (15% EtOAc/hexanes),
9d:10d (56 mg, 56%, 72:28, 44% de) as a yellow oil. Rf 0.25 (30%
EtOAc/hexanes); IR (neat): nÄ 3017 2890, 1760, 1720, 1670, 1474 1456,
1215, 1183, 1162 cmÀ1; 1H NMR (200 MHz, CDCl3, 258C): d 1.03 (s, 9H),
1.22 1.98 (m, 6H), 2.16 (dd, J 15.6, 8.3 Hz, 2H), 3.64 (s, 3H), 3.9 (dd, J
10.3, 2.9 Hz, 0.72H), 4.42 (m, 0.28H), 6.06 (s, 0.72H), 6.18 (s, 0.28H), 7.37
7.65 ppm (m, 5H); 13C NMR (50 MHz, CDCl3, 258C): d 24.0 (CH2), 25.1
(3 Â CH3), 25.9 (CH2), 33.5 (CH2), 34.9 (CH2), 33.5 (CH2), 34.9 (CH2), 36.9
(C), 51.5 (CH3), 57.6 (CH), 95.4 (CH), 126.5 (2 Â CH), 128.8 (2 Â CH), 130.6
(CH), 135.6 (C), 172.2 (C), 173.4 (C), 173.5 ppm (C); MS (70 eV, EI): m/z
(neat): nÄ 3391, 2962 2874, 1796, 1201 1115 cmÀ1
;
1H NMR (200 MHz,
CDCl3, 258C): d 0.99 (s, 9H), 1.55 1.96 (m, 6H), 3.60 3.71 (m, 2H), 4.27
(ddd, J 6.8, 4.4, 1.0 Hz, 0.92H), 4.38 (ddd, J 6.8, 4.4, 1.0 Hz, 0.08H), 5.15
(d, J 1.5 Hz, 0.92H), 5.28 ppm (d, J 1.5 Hz, 0.08H); 13C NMR (50 MHz,
CDCl3, 258C): d 21.3 (CH2), 23.4 (3 Â CH3), 30.3 (CH2), 34.2 (C), 62.4
(CH2), 75.0 (CH), 109.3 (CH), 173.5 ppm (C); MS (FAB): m/z (%): 217 (54)
[M H], 147 (100); HRMS (FAB): m/z: calcd for C11H21O4: 217.1440
[M H]; found: 217.1447.
(2S,5x)-2-(tert-Butyl)-5-(13-hydroxytridecyl)-1,3-dioxolan-4-one (7 f:8 f):
Following the general experimental procedure, a mixture containing
dioxolanone 1 (100 mg, 0.64 mmol) and 12-iodo-1-dodecanol (600 mg,
1.92 mmol) was treated with CuI (244 mg, 1.28 mmol) and Zn (251 mg,
3.84 mmol) to give, after column chromatography (20% EtOAc/hexanes),
7 f:8 f (170 mg, 57%, 92:8, 84% de) as a yellow oil. Rf 0.5 (50% EtOAc/
(%): 362 (7) [M H], 361 (10) [M ], 346 (14) [M À CH3), 330 (5) [M À
CH3O], 304 (17) [M À C4H9], 105 (100); HRMS (EI): m/z: calcd for
hexanes); IR (neat): nÄ 3363, 2925 2854, 1800, 1197 cmÀ1
;
1H NMR
C20H27NO5: 361.1889 [M ]; found: 361.1892; elemental analysis calcd (%)
(200 MHz, CDCl3, 258C): d 0.98 (s, 9H), 0.87 0.95 (m, 2H), 1.18 1.90
(m, 20H), 3.48 (q, J 6.8 Hz, 1H), 3.65 (t, J 6.3 Hz, 2H), 4.25 (ddd, J
11.7, 4.4, 1.5 Hz, 0.92H), 4.28 (ddd, J 11.7, 4.4, 1.5 Hz, 0.08H), 5.12 (d, J
1.5 Hz, 0.92H), 5.25 ppm (d, J 1.5 Hz, 0.08H); 13C NMR (50 MHz,
CDCl3, 258C): d 23.2 (CH2), 23.4 (3 Â CH3), 24.9 (CH2), 25.7 (CH2), 29.2
(CH2), 29.3 (CH2), 29.4 (CH2), 29.5 (CH2), 29.5 (CH2), 30.6 (CH2), 32.8
(CH2), 34.2 (C), 63.0 (CH2), 75.1 (CH), 109.3 (CH), 173.7 ppm (C); MS
for C20H27NO5 (361.4): C 66.46, H 7.53, N 3.88; found: C 66.17, H 7.52, N
3.71.
(2S,4x)-3-Benzoyl-2-(tert-butyl)-4-(4-hydroxybutyl)-5-oxazolidinone
(9e:10e): Following the general experimental procedure,
a mixture
containing (60 mg, 0.231 mmol) and 3-iodo-1-propanol (44 mL,
2
0.46 mmol) was treated with CuI (88 mg, 0.46 mmol) and Zn (91 mg,
1.39 mmol) to give, after column chromatography (40% EtOAc/hexanes),
9e:10e (28 mg, 38%, 77:23, 54% de) as a yellow oil. Rf 0.2 (50% EtOAc/
hexanes); IR (neat): nÄ 3647, 2980 2947, 1843, 1714, 1472 1456, 1253,
1213 cmÀ1; 1H NMR (200 MHz, CDCl3, 258C): d 1.03 (s, 9H), 1.43 2.02
(m, 6H), 3.50 (t, J 5.8 Hz, 2H), 3.91 (dd, J 10.3, 2.9 Hz, 0.77H), 4.44 (m,
0.23H), 6.07 (s, 0.77H), 6.19 (s, 0.23H), 7.38 7.65 ppm (m, 5H); 13C NMR
(50 MHz, CDCl3, 258C): d 22.8 (CH2), 25.1 (3 Â CH3), 31.6 (CH2), 35.0
(CH2), 36.9 (C), 57.7 (CH), 62.2 (CH2), 95.4 (CH), 126.5 (2 Â CH), 128.8
(2 Â CH), 130.6 (CH), 135.6 (C), 172.4 (C), 173.7 ppm (C); MS (70 eV, EI):
(FAB): m/z (%): 343 (64) [M H], 154 (100); HRMS (FAB): m/z: calcd
for C20H39O4: 343.2848 [M H]; found: 343.2836.
Methyl (2R)-2-[(tert-butoxycarbonyl)amino]-4-[(2S,4S)-2-(tert-butyl)-5-
oxo-1,3-dioxolan-4-yl]butanoate (7g): Following the general experimental
procedure, dioxolanone
1 (60 mg, 0.384 mmol) and 6g (242 mg,
0.768 mmol) was treated with CuI (219 mg, 1.152 mmol) and Zn (176 mg,
2.688 mmol) to give, after column chromatography (20% EtOAc/hexanes),
7g and 8g (91 mg and 8 mg, respectively, 72%, 92:8, 84% de) as colorless
oils. Rf 0.30 (7g) and 0.35 (8g) (30% EtOAc/hexanes); 7g: IR (neat): nÄ
2974 2876, 1797, 1745, 1714, 1199 1171 cmÀ1; 1H NMR (200 MHz, CDCl3,
258C): d 0.98 (s, 9H), 1.45 (s, 9H), 1.77 2.01 (m, 4H), 3.76 (s, 3H), 4.25
(m, 1H), 4.35 (m, 1H), 5.14 ppm (d, J 1.0 Hz, 1H); 13C NMR (50 MHz,
CDCl3, 258C): d 23.4 (3 Â CH3), 26.7 (CH2), 28.2 (CH2), 28.2 (3 Â CH3),
34.2 (C), 52.4 (CH3), 74.5 (CH), 109.4 (2 Â CH), 172.8 ppm (C); MS (CI):
m/z (%): 320 (9) [M H], 319 (11) [M ], 304 (16) [M À CH3], 262 (7)
[M À C4H9), 105 (100); HRMS (EI): m/z: calcd for C18H25NO4: 319.1784
[M ]; found: 319.1795.
(2S,4x)-3-Benzoyl-2-(tert-butyl)-4-(13-hydroxytridecyl)-5-oxazolidinone
(9 f:10 f): Following the general experimental procedure,
a mixture
containing (80 mg, 0.308 mmol) and 12-iodo-1-dodecanol (193 mg,
2
m/z (%): 360 (16) [M H], 260 (100); HRMS (CI): m/z: calcd for
0.617 mmol) was treated with CuI (117 mg, 0.617 mmol) and Zn (121 mg,
1.848 mmol) to give, after column chromatography (20% EtOAc/hexanes),
9 f:10 f (96 mg, 74%, 77:23, 54% de) as a yellow oil. Rf 0.15 (30%
EtOAc/hexanes); IR (neat): nÄ 3676, 2880 2850, 1780, 1675, 1485 1450,
1245, 1212 cmÀ1; 1H NMR (200 MHz, CDCl3, 258C): d 1.05 (s, 9H), 1.10
2.00 (m, 24H), 3.65 (t, J 6.3 Hz, 2H), 3.88 (dd, J 9.8, 2.9 Hz, 0.77H),
4.43 (m, 0.23H), 6.07 (s, 0.77H), 6.20 (s, 0.23H), 7.40 7.64 ppm (m, 5H);
13C NMR (50 MHz, CDCl3, 258C): d 24.7, 25.2, 25.7, 26.4, 28.7, 29.1, 29.3,
29.4, 29.4, 29.5, 29.6, 32.8, 35.4, 36.8, 39.8, 57.8, 63.0, 95.3, 126.5, 128.7, 129.0,
C17H29NO7: 360.2022 [M H]; found: 360.2025.
(2S,4x)-3-Benzoyl-2-(tert-butyl)-4-hexyl-5-oxazolidinone (9a:10a): Fol-
lowing the general experimental procedure, a mixture containing oxazo-
lidinone 2 (77 mg, 0.297 mmol) and 1-iodopentane (80 mL, 0.617 mmol) was
treated with CuI (117 mg, 0.617 mmol) and Zn (121 mg, 1.848 mmol) to
give, after column chromatography (12% EtOAc/hexanes), 9a:10a (71 mg,
72%, 88:12, 76% de) as a yellow solid. Rf 0.5 (30% EtOAc/hexanes);
m.p. 26 288C; IR (neat): nÄ 3043 2865, 1712, 1670, 1474 1458, 1257,
1213 cmÀ1; 1H NMR (200 MHz, CDCl3, 258C): d 0.84 (t, J 6.8 Hz, 3H),
1.04 (s, 9H), 0.94 2.04 (m, 10H), 3.88 (dd, J 10.2, 3.4 Hz, 1H), 6.06 (s,
0.88H), 6.19 ppm (s, 0.12H); 13C NMR (50 MHz, CDCl3, 258C): d 13.9
(CH3), 22.4 (CH2), 25.2 (3 Â CH3), 26.4 (CH2), 28.4 (CH2), 31.2 (CH2), 35.4
(CH2), 36.9 (C), 57.8 (CH), 95.4 (CH), 126.5 (2 Â CH), 128.7 (2 Â CH), 130.5
(CH), 135.7 (C), 172.4 (C), 173.8 ppm (C); MS (70 eV, EI): m/z (%): 332 (2)
130.5, 135.7, 172.4, 173.8 ppm; MS (70 eV, EI): m/z (%): 446 (15) [M H],
431 (8) [M À CH3], 388 (12) [M À C4H9], 105 (100); HRMS (EI): m/z:
calcd for C27H43NO4: 445.3192 [M ]; found: 445.3193.
Methyl (2R)-4-[(2S,4S)-3-benzoyl-2-(tert-butyl)-5-oxo-4-oxazolidinyl]-2-
[(tert-butoxycarbonyl)amino]butanoate (9g): Following the general ex-
perimental procedure,
a mixture containing oxazolidinone 2 (95 mg,
[M H], 316 (20) [M À CH3], 274 (100); HRMS (EI): m/z: calcd for
0.374 mmol) and 6g (200 mg, 0.634 mmol) was treated with CuI (142 mg,
0.748 mmol) and Zn (147 mg, 2.244 mmol) to give, after column chroma-
tography (25% EtOAc/hexanes), 9g and 10g (85 mg and 21 mg, respec-
tively, 61%, 80:20, 60% de) as pale yellow oils. 9g: Rf 0.2 (30% EtOAc/
hexanes); IR (neat): nÄ 3060 2875, 1789, 1743, 1712, 1667, 1512 1449,
1244, 1199 cmÀ1; 1H NMR (200 MHz, CDCl3, 258C): d 1.03 (s, 9H), 1.45
(s, 9H), 1.88 2.14 (m, 4H), 3.71 (s, 3H), 4.45 (m, 1H), 5.02 (m, 1H), 6.07 (s,
1H), 7.37 7.66 ppm (m, 5H); 13C NMR (50 MHz, CDCl3, 258C): d 25.1
(3 Â CH3), 28.3 (3 Â CH3), 30.1 (CH2), 31.5 (CH2), 36.8 (C), 36.9 (C), 52.4
C20H29NO3: 331.2147 [M ]; found: 331.2150.
(2S,4x)-3-Benzoyl-2-(tert-butyl)-4-cyclohexylmethyl-5-oxazolidinone
(9c:10c):[17] Following the general experimental procedure, a mixture
containing
2 (80 mg, 0.308 mmol) and cyclohexyl iodide (80 mL,
0.617 mmol) was treated with CuI (117 mg, 0.617 mmol) and Zn (121 mg,
1.848 mmol) to give, after column chromatography (10% EtOAc/hexanes),
9c:10c (100 mg, 94%, 91:9, 82% de) as a yellow solid. Rf 0.55 (30%
EtOAc/hexanes); IR (neat): nÄ 2952 2879, 1877, 1712, 1480 1460, 1254,
4184
¹ 2003 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Chem. Eur. J. 2003, 9, 4179 4187